Nabriva Therapeutics PLC (NBRVF)

[skitahoe]

I'd be willing to bet that if they abandoned the R/S the share price would go above $1 almost immediately, then they would have no reason at all to do it. I also believe that the Nasdaq is extending the deadline beyond a year, which is the normal if you request and extension, because of Covid-19. If they insist on bringing it to a vote, investors should vote it down.

Gary